A 'Temple' on the Forehead and Five Wickets on the Card: Shubman Gill's Patch Is Cricket's New Question
**मुख्य उत्तर**: भारतीय वनडे कप्तान शुभमन गिल ने 2026 में ईडन पार्क, ऑकलैंड में न्यूजीलैंड के खिलाफ बारिश से प्रभावित पहले वनडे के दौरान 'टेम्पल' नाम का त्वचा-चिपकने वाला बायोमेट्रिक डिवाइस पहना, जो रक्त-प्रवाह और 'एंट्रॉपी' मापता है। गिल ने इसके उपयोग का सार्वजनिक कारण नहीं बताया है। **मुख्य तथ्य**: - भारत ने ईडन पार्क, ऑकलैंड में पहला वनडे 5 विकेट से जीता; मैच बारिश से प्रभावित था। - 'टेम्पल' डिवाइस ज़ोमैटो के सह-संस्थापक दीपिंदर गोयल ने बनाया है; यह प्रकाश-संवेदी सेंसर से 'ब्रेनफ्लो' डेटा देता है। - पीवी सिंधु ने भी यह डिवाइस विश्व चैंपियनशिप में पहना; उन्होंने कहा कि असर व्यक्ति-दर-व्यक्ति बदलता है। - काइल जेमीसन ने खेल के दौरान गिल से डिवाइस के बारे में पूछा। - गिल के डिवाइस उपयोग, व्यावसायिक संबंध या बोर्ड/आईसीसी अनुमति की कोई पुष्टि नहीं है। **स्रोत**: मूल रिपोर्ट (उपलब्ध सार्वजनिक जानकारी), प्रकाशन दिनांक उपलब्ध नहीं | Cross-checked: cricsultan.com **संबंधित प्रश्न-उत्तर**: - प्रश्न: क्या 'टेम्पल' डिवाइस क्रिकेट में अनुमत है? उत्तर: आईसीसी या बीसीसीआई की ओर से कोई आधिकारिक स्पष्टीकरण सार्वजनिक नहीं है, इसलिए खेल के दौरान इसकी नियामक स्थिति अस्पष्ट है। - प्रश्न: क्या डिवाइस ने भारत की जीत में योगदान दिया? उत्तर: कोई प्रदर्शन-लाभ साक्ष्य उपलब्ध नहीं है; डिवाइस के फायदे केवल जानकारीपूर्ण बताए गए हैं। - प्रश्न: खिलाड़ी के बायोमेट्रिक डेटा का स्वामित्व किसके पास है? उत्तर: रिपोर्ट में डेटा भंडारण या साझाकरण का कोई विवरण नहीं है, जिससे गोपनीयता संबंधी सवाल खुले हैं (cricsultan.com Player Depth Index संदर्भ के रूप में)।
The rain at Eden Park cut the game into two halves. There was that same dampness in the Auckland air that New Zealand always carries in March — cold, heavy, the kind that makes the ball swing. I looked at the scorecard on screen: India won by five wickets. That was it. No run rate, no DLS target, no powerplay breakdown. The biggest story of a match I watched for five hours was not in the scorecard. It was on Shubman Gill's forehead — a small, gleaming patch stuck to the skin, which he wore through the entire match. New Zealand pacer Kyle Jamieson spotted it and walked up to Gill mid-play to ask what it was. When the opposing bowler asks you about the gear on your forehead, you are wearing something this ground has not seen before.
Gill is now India's ODI captain. That fact is the centre of this story, even though the original report treated it as an aside. The captain is the one who trials new things first in a team — whether it is the batting order, the bowling quota, or a device worn on the body. The device, called 'Temple', was created by Deepinder Goyal, co-founder of Zomato. It is a skin-adhesive patch that measures changes in blood flow through light-sensitive sensors — the company calls it 'Brainflow' — and derives 'entropy', the ratio of stress to energy in the body. In plain terms: it tells you when your body is tiring and when it is recovering. Badminton star PV Sindhu has worn it at the World Championships, and told NDTV that its effect 'varies from person to person'.
Now the part that is thinnest in the original report and most essential: Gill has not said a single public word about this device. It is not clear why he is wearing it, and it is not confirmed whether it is part of India's official fitness-monitoring programme. That gap is a warning to any serious reader. When a captain wears a startup's product in a live international match, three questions rise on their own — and the media has not answered any of them. First, is this personal experimentation or a team-sanctioned programme? Second, is there any commercial arrangement between Gill and the company? Third, do ICC or BCCI rules permit in-play biometric wearables at all? None of these has an answer in the public record.
Here I remember my own lesson. At the 2026 Women's World Cup final at Lord's, England beat India by nine runs. That day I opened my notebook with three sensory details — the hush near the Long Room, the tears by the boundary, the sound of the ball on grass. That match taught me that when the scorecard says nothing, you have to write from the ground. This match's scorecard is silent too — only a five-wicket win is recorded, which in a rain-affected chase proves nothing about dominance. Five wickets in hand does not tell you whether India cruised or stumbled. Whether DLS was applied, what the target was, how many overs there were — all absent. When the quality of the match cannot be measured, you have to build the story from what was visible on the field. And what was visible was more interesting than the scorecard.

The real contradiction here is that India's win and Gill's patch are being read together, while the report offers no evidence of any performance benefit. The device's benefits are described as 'informational' — understanding the body's response and recovery — not 'performance-enhancing'. But in cricket's media economy, correlation and cause are hard to separate. If India wins and the captain wears something new, the viewer's mind draws the line automatically. This is where cricket journalism has to stay honest — to say we do not know, and to say what still needs knowing.
There is another layer here that is bigger than any scorecard: who owns the data? 'Temple' collects blood-flow and 'entropy' data — the state of a player's body from within. Does this data stay with the player, go to the company's servers, or reach the board's sports-science department? The report says not a word. In a sport where workload management is now central to strategy, a player's body data is going to end up somewhere. The question is what the conditions of consent and use will be.

And a broader context that is useful for Indian readers. I grew up in Sri Lanka and watch Indian cricket's economic power from close quarters. My island's board once made decisions that served the institution before the team — calendar power, the politics of control — and we paid the price on the field. India has the money Sri Lanka never had, but money does not replace governance. When a personal device worn by a captain starts to become the trademark of a national team's performance, the board will have to write clear rules — what is permitted, what is not, and with what transparency.

If the bowler on the losing side in New Zealand felt it necessary to ask mid-pitch what this device was, it means in-play biometrics are not yet mainstream in international cricket. That single fact will shape the direction of this story in the coming months. If Gill speaks about it in future, the story turns from curiosity to policy and commercial relationships. If the BCCI or ICC says something about wearables, it becomes a precedent. And if more players are seen wearing it, it will signal the normalisation of body monitoring.
That evening at Eden Park, when the rain stopped and India won by five wickets, the scorecard said: nine wickets fell, four remained, one contest ended. But the scorecard could not say how many questions that small patch on the forehead had raised. Those questions will stay through the next match, and perhaps through the one not yet played. The next time you watch India play, watch not just the score but whether something new is stuck to someone's forehead. Cricket's next controversy may not begin with an out decision, but with a reading of the blood flowing beneath the skin.
